NRX Pharmaceuticals Inc (NRXP) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.93
• Market Cap: $56.55M
• EPS: $-2.31
• 52-Week High: $3.84
• 52-Week Low: $1.58

Market Sentiment

NRX Pharmaceuticals Inc currently has a Bullish sentiment score of 0.36.

About NRX Pharmaceuticals Inc

NRx Pharmaceuticals, Inc. (NRXP) is a clinical-stage biopharmaceutical company headquartered in Wilmington, Delaware, dedicated to developing pioneering therapies for severe central nervous system disorders and respiratory diseases. The company is committed to addressing unmet medical needs through its proprietary technologies and innovative research, resulting in a promising pipeline that targets critical health challenges. As NRX advances its drug candidates through rigorous clinical trials...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for NRX Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does NRXP pay dividends?

NRX Pharmaceuticals Inc (NRXP) does not currently pay a regular dividend.

What is NRXP's market cap?

NRX Pharmaceuticals Inc (NRXP) has a market capitalization of $56.55M with a current stock price of $1.93.